Literature DB >> 16633023

Fungal keratitis at the new york eye and ear infirmary.

David C Ritterband1, John A Seedor, Mahendra K Shah, Richard S Koplin, Steven A McCormick.   

Abstract

INTRODUCTION: This study was designed to review the clinical experience at our institution with fungal keratitis during a 16-year period.
MATERIALS AND METHODS: A review of the clinical and microbiology records of the New York Eye and Infirmary identified 61cases of fungal keratitis in 57 patients between January 1, 1987 and June 1, 2003. The medical records of all patients were retrospectively reviewed to better delineate patient demographics, risk factors, etiologic organisms, treatment, and outcomes.
RESULTS: A total of 5083 positive corneal cultures were recorded'from January 1, 1987 to June 1, 2003. Sixty-one eyes in 57 patients (37 women) were positive for fungus (1.2%). Three'patients had bilateral simultaneous infections. Candida albicans accounted for 29 of 61 cases (48%). Human immunodeficiency virus (HIV) seropositivity (15 eyes), chronic ocular surface disease (14 eyes), and trauma (7 eyes) were the most commonly associated risk factors.
CONCLUSIONS: Our experience with fungal keratitis in the northeastern United States appears to be different than those reported from other areas of the United States. Serologic positivity for HIV and chronic ocular surface disease were the most common associated risk factors followed by trauma, herpes simplex keratitis, and contact lens use. Candida species predominated, whereas filamentous fungi were uncommon.

Entities:  

Mesh:

Year:  2006        PMID: 16633023     DOI: 10.1097/01.ico.0000177423.77648.8d

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  37 in total

1.  [The German keratomycosis registry : Initial results of a multicenter survey].

Authors:  M Roth; L Daas; A Renner-Wilde; N Cvetkova-Fischer; M Saeger; M Herwig-Carl; M Matthaei; A Fekete; V Kakkassery; G Walther; M von Lilienfeld-Toal; C Mertens; J Lenk; J Mehlan; C Fischer; M Fuest; S Kroll; W Bayoudh; A Viestenz; A Frings; C R MacKenzie; E M Messmer; B Seitz; O Kurzai; G Geerling
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Fusarium keratitis at a tertiary eye care centre in India.

Authors:  Sujata Das; Savitri Sharma; Samir Mahapatra; Srikant K Sahu
Journal:  Int Ophthalmol       Date:  2014-06-15       Impact factor: 2.031

3.  Fungal keratitis in the Republic of Ireland.

Authors:  S Farrell; E McElnea; S Moran; S Knowles; C C Murphy
Journal:  Eye (Lond)       Date:  2017-05-19       Impact factor: 3.775

4.  Topical flagellin-mediated innate defense against Candida albicans keratitis.

Authors:  Nan Gao; Ashok Kumar; Hui Guo; Xinyi Wu; Michelle Wheater; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

Review 5.  Penicillium keratitis in a HIV-infected patient.

Authors:  Orapin Anutarapongpan; Onsiri Thanathanee; Olan Suwan-Apichon
Journal:  BMJ Case Rep       Date:  2016-08-17

Review 6.  Freshwater Fungal Infections.

Authors:  Dennis J Baumgardner
Journal:  J Patient Cent Res Rev       Date:  2017-01-31

7.  In the aftermath of the Fusarium keratitis outbreak: What have we learned?

Authors:  Arthur B Epstein
Journal:  Clin Ophthalmol       Date:  2007-12

8.  Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection.

Authors:  Xiaowei Liu; Nan Gao; Chen Dong; Li Zhou; Qing-Sheng Mi; Theodore J Standiford; Fu-Shin X Yu
Journal:  Eur J Immunol       Date:  2014-08-14       Impact factor: 5.532

9.  Ocular mycosis at a referral center in Saudi Arabia: A 20-year study.

Authors:  Sabah S Jastaneiah; Ali A Al-Rajhi; David Abbott
Journal:  Saudi J Ophthalmol       Date:  2011-04-30

10.  Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.

Authors:  Catherine Q Sun; Prajna Lalitha; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Catherine E Oldenburg; Kathryn J Ray; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Ophthalmology       Date:  2014-04-16       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.